November 5, 2021 8:30 am

Pfizer: Our New COVID-19 Pill Cuts Severe Illness by 89%

Pfizer says the company stopped clinical trials for its new coronavirus antiviral treatment early because the data was overwhelmingly successful.

US & World Videos

2:19

San Francisco barbershop struggles to stay open after pandemic
0:51

Alameda County using dogs to detect COVID
3:57

Interview: Doctor's perspective on COVID 4 years after shutdown started
2:27

Marking 4 years since COVID-19 shut down the Bay Area
2:09

CDC updates COVID isolation guidelines
Exit mobile version